Effect of insulin and heparin on glucose-induced vascular damage in cell culture
Effect of insulin and heparin on glucose-induced vascular damage in cell culture. Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is no...
Saved in:
Published in: | Kidney international Vol. 57; no. 6; pp. 2492 - 2501 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
01-06-2000
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Effect of insulin and heparin on glucose-induced vascular damage in cell culture.
Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications.
ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA).
LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium.
These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose. |
---|---|
AbstractList | Effect of insulin and heparin on glucose-induced vascular damage in cell culture.
Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications.
ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA).
LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium.
These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose. Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications. ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA). LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium. These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose. Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications. ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA). LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium. These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose. |
Author | Taylor, Catherine A. Kohno, Masakazu Mandal, Anil K. Puchalski, Jonathan T. Lemley-Gillespie, Susan |
Author_xml | – sequence: 1 givenname: Anil K. surname: Mandal fullname: Mandal, Anil K. email: tfischer@med-spec.com – sequence: 2 givenname: Jonathan T. surname: Puchalski fullname: Puchalski, Jonathan T. – sequence: 3 givenname: Susan surname: Lemley-Gillespie fullname: Lemley-Gillespie, Susan – sequence: 4 givenname: Catherine A. surname: Taylor fullname: Taylor, Catherine A. – sequence: 5 givenname: Masakazu surname: Kohno fullname: Kohno, Masakazu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/10844618$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1PxCAQholZ437oT9AQ761QoNKjbvxKTPSwd0Jh0G66dIWt0X8vtZuNN09MmOcdmGeOJr7zgBCmJKeEl1frnIqCZfRaiLwghOSEUCLzryM0OzQmaEaIFFkhmJyieYzrBMqKkRM0TTDnJZUz9HrnHJgd7hxufOzbxmPtLX6HrQ6p7jx-a3vTRcgab3sDFn_qaPpWB2z1Rr9BimEDbYvT5a4PcIqOnW4jnO3PBVrd362Wj9nzy8PT8uY5M7ysdlnBtZVWioqw0gDYsqpL4wi7dtJZy0UtbE05tTWnzNWyqFjJwZRguXPcCLZAl-PYbeg-eog7te764NOLqqBJBqsISZAcIRO6GAM4tQ3NRodvRYkaRKq1GnypwZcaRKpfkeorRS_28_t6A_ZPcDSXgPMR8HpY-wBwXlGRNC_Q7diHJOGzgaCiacAng01IwpXtmv9_8QNWsJBS |
CitedBy_id | crossref_primary_10_1016_j_vph_2013_08_001 crossref_primary_10_4236_ojim_2011_13017 crossref_primary_10_1016_j_trsl_2008_12_007 crossref_primary_10_1186_1475_2840_4_12 crossref_primary_10_1074_jbc_M608565200 crossref_primary_10_1089_ars_2013_5695 crossref_primary_10_1186_1475_2840_8_46 crossref_primary_10_1016_j_ijpharm_2023_122987 crossref_primary_10_1016_j_vph_2014_05_001 crossref_primary_10_1016_j_ijcha_2017_03_004 |
Cites_doi | 10.1161/01.HYP.4.5.681 10.1016/0014-2999(95)00534-X 10.7326/0003-4819-128-7-199804010-00001 10.1016/S0140-6736(95)90403-4 10.1172/JCI116805 10.1007/BF00398060 10.1016/0168-8227(94)90107-4 10.1046/j.1523-1755.1999.00591.x 10.1016/0026-0495(94)90270-4 10.1083/jcb.86.2.688 10.1038/ki.1995.441 10.1002/(SICI)1097-4652(199604)167:1<131::AID-JCP15>3.0.CO;2-E 10.1007/BF02631069 10.1038/ki.1995.147 10.1016/S0140-6736(98)07019-6 10.1681/ASN.V581600 10.1016/0014-5793(90)80276-O 10.1136/bmj.317.7160.703 10.1016/S0022-2143(99)90006-9 10.1055/s-0029-1211724 10.1006/jsre.1994.1195 10.1161/01.HYP.21.3.353 |
ContentType | Journal Article |
Copyright | 2000 International Society of Nephrology Copyright Nature Publishing Group Jun 2000 |
Copyright_xml | – notice: 2000 International Society of Nephrology – notice: Copyright Nature Publishing Group Jun 2000 |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QP 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P NAPCQ PQEST PQQKQ PQUKI PRINS |
DOI | 10.1046/j.1523-1755.2000.00108.x |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Medical Library (Alumni) ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE ProQuest One Academic Eastern Edition |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1523-1755 |
EndPage | 2501 |
ExternalDocumentID | 980026251 10_1046_j_1523_1755_2000_00108_x 10844618 4491589 S0085253815470085 |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 1CY 29L 2WC 36B 39C 3O- 3V. 4.4 457 53G 5GY 5RE 5VS 6I. 6PF 7RV 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACTN AAEDW AAFTH AAIAV AAKUH AALRI AAQFI AAWTL AAXUO ABAWZ ABJNI ABLJU ABMAC ABOCM ABUWG ABVKL ACGFO ACGFS ACPRK ADBBV ADEZE ADFRT ADQMX AENEX AEXQZ AFEBI AFKRA AFTJW AGHFR AHMBA AHPSJ AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BENPR BFHJK BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 DIK DU5 EBS EJD EX3 F5P FDB FRP FYUFA GX1 HMCUK HZ~ IHE J5H JSO KQ8 L7B LH4 LW6 M1P M41 MJL N4W NAPCQ NCXOZ O9- OK1 P2P P6G PQQKQ PROAC PSQYO Q2X R9- RIG RNS ROL SDH SSZ TR2 UKHRP W2D WOW X7M XVB YFH YOC YUY ZA5 ZCG ZGI ZXP - 08R 0R 55 ABFLS ABPTK ADBIT AFETI BBAFP GJ HZ IPNFZ PQEST PQUKI PRINS XIP 0SF ADVLN AFJKZ AKRWK ALIPV CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7XB 8FK K9. |
ID | FETCH-LOGICAL-c469t-24ad8d859036ceed69b6cf037f8fdd45b5db141db413fb829364ec6ed4ff4c53 |
ISSN | 0085-2538 |
IngestDate | Thu Oct 10 15:57:33 EDT 2024 Thu Nov 21 22:38:28 EST 2024 Sat Sep 28 07:35:37 EDT 2024 Thu Oct 07 19:41:09 EDT 2021 Fri Feb 23 02:12:32 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | diabetic vascular complications endothelial cells D-glucose cell adhesion |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c469t-24ad8d859036ceed69b6cf037f8fdd45b5db141db413fb829364ec6ed4ff4c53 |
OpenAccessLink | https://dx.doi.org/10.1046/j.1523-1755.2000.00108.x |
PMID | 10844618 |
PQID | 210103900 |
PQPubID | 47198 |
PageCount | 10 |
ParticipantIDs | proquest_journals_210103900 crossref_primary_10_1046_j_1523_1755_2000_00108_x pubmed_primary_10844618 nature_primary_4491589 elsevier_sciencedirect_doi_10_1046_j_1523_1755_2000_00108_x |
ProviderPackageCode | ADQMX |
PublicationCentury | 2000 |
PublicationDate | 2000-06-01 |
PublicationDateYYYYMMDD | 2000-06-01 |
PublicationDate_xml | – month: 06 year: 2000 text: 2000-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | Kidney international |
PublicationTitleAlternate | Kidney Int |
PublicationYear | 2000 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Mueller, Fritsche, Haslinger, Landgraf (bb0070) 1997; 105 Sank, Wei, Reid (bb0010) 1994; 57 Rosenzweig, Kanwar (bb0105) 1982; 47 Curcio, Ceriello (bb0020) 1992; 28A Metsarinne, Saijonmaa, Yki-Jarvinen, Fyhrquist (bb0080) 1994; 43 Kamoi, Ishibashi, Yamaji (bb0015) 1994; 24 Imai, Hirata, Emori, Marumo (bb0090) 1993; 21 Kobayashi, Ishida, Moriya, Mori, Fukuda, Takamura (bb0135) 1999; 133 Yokoyama, Sato, Dkudaira, Morita, Takahashi, Suzuki, Sakai, Iwamoto (bb0125) 1999; 56 Ferri, Pittoni, Piccoli, Laurenti, Cassons, Bellinic Properzi, Valesini, Demattia, Santucci (bb0100) 1995; 80 Kanwar, Linker, Farquhar (bb0110) 1980; 86 Kasinath, Grellier, Ghosh Choudhury, Abboud (bb0120) 1996; 167 Inoguchi, Xia, Kunisuki, Higashi, Feener, King (bb0095) 1994; 267 Susic, Mandal, Radjkovic, Vulovic, Kentera (bb0145) 1988; 111 UK Prospective Diabetes Study Group (bb0035) 1998; 317 Tamsma, Vandenborn, Bruijin, Assinan, Weening, Berden, Wieslander, Shrama, Hermans, Veerkamp, Lenkes, Vander Woude (bb0115) 1994; 37 Yokokawa, Tahara, Kohno, Mandal, Yanagisawa, Takeda (bb0055) 1993; 92 Myrup, Hansen, Jensen, Kefoed-Eneroldsen, Feldt-Rasmussen, Gram, Kluft, Jespersen, Deckert (bb0130) 1995; 345 Susic, Mandal, Kentera (bb0140) 1982; 4 Mandal, Lyden, Saklayen (bb0040) 1995; 47 Graier, Grubnethal, Dittrich, Wuscher, Kestner (bb0060) 1995; 294 UK Prospective Diabetics Study Group (bb0030) 1998; 352 Takeuchi, Throckmorton, Brogden, Yoshizawa, Rasmussen, Kashgarian (bb0065) 1995; 268 Mandal, Lyden, Fazel, Saklayen, Mehrotra, Mahling, Taylor, Yokokawa, Colvin (bb0045) 1995; 48 Yokokawa, Mandal, Kohno, Horio, Murakawa, Yasunari, Takeda (bb0050) 1992; 263 The Diabetes Control Complications Trial Research Group (bb0025) 1998; 128 Cosio (bb0075) 1995; 5 Yamauchi, Ohnaka, Takayanagi, Umeda, Nawata (bb0085) 1990; 267 Kanwar, YS, Linker, A, Farquhar, MG 1980; 86 Takeuchi, A, Throckmorton, DC, Brogden, AP, Yoshizawa, N, Rasmussen, H, Kashgarian, M 1995; 268 Myrup, B, Hansen, PM, Jensen, T, Kefoed-Eneroldsen, A, Feldt-Rasmussen, B, Gram, J, Kluft, C, Jespersen, J, Deckert, T 1995; 345 1998; 317 Kamoi, K, Ishibashi, M, Yamaji, T 1994; 24 Curcio, A, Ceriello, A 1992; 28A Yokokawa, K, Mandal, AK, Kohno, M, Horio, T, Murakawa, K, Yasunari, K, Takeda, T 1992; 263 1998; 352 Metsarinne, K, Saijonmaa, O, Yki-Jarvinen, H, Fyhrquist, F 1994; 43 Susic, D, Mandal, AK, Kentera, D 1982; 4 Imai, T, Hirata, Y, Emori, T, Marumo, F 1993; 21 Ferri, C, Pittoni, V, Piccoli, A, Laurenti, O, Cassons, MR, Bellinic Properzi, G, Valesini, G, Demattia, G, Santucci, A 1995; 80 Kasinath, BS, Grellier, P, Ghosh Choudhury, G, Abboud, SL 1996; 167 Inoguchi, T, Xia, P, Kunisuki, M, Higashi, S, Feener, EP, King, GL 1994; 267 Mandal, AK, Lyden, TW, Saklayen, MG 1995; 47 Tamsma, JT, Vandenborn, J, Bruijin, JA, Assinan, KJM, Weening, JJ, Berden, JHM, Wieslander, J, Shrama, E, Hermans, J, Veerkamp, JH, Lenkes, HHPJ, Vander Woude, FJ 1994; 37 Kobayashi, S, Ishida, A, Moriya, TT, Mori, N, Fukuda, T, Takamura, T 1999; 133 Mandal, AK, Lyden, TW, Fazel, A, Saklayen, MG, Mehrotra, B, Mahling, B, Taylor, CA, Yokokawa, K, Colvin, RB 1995; 48 Yokokawa, K, Tahara, H, Kohno, M, Mandal, AK, Yanagisawa, M, Takeda, T 1993; 92 Susic, D, Mandal, AK, Radjkovic, G, Vulovic, D, Kentera, D 1988; 111 Cosio, F 1995; 5 Yokoyama, H, Sato, K, Dkudaira, M, Morita, C, Takahashi, C, Suzuki, D, Sakai, H, Iwamoto, Y 1999; 56 Rosenzweig, LJ, Kanwar, YS 1982; 47 1998; 128 Yamauchi, T, Ohnaka, K, Takayanagi, R, Umeda, F, Nawata, H 1990; 267 Graier, WF, Grubnethal, I, Dittrich, P, Wuscher, TC, Kestner, GM 1995; 294 Sank, A, Wei, D, Reid, J 1994; 57 Mueller, HK, Fritsche, U, Haslinger, A, Landgraf, R 1997; 105 Metsarinne (10.1046/j.1523-1755.2000.00108.x_bb0080) 1994; 43 Susic (10.1046/j.1523-1755.2000.00108.x_bb0145) 1988; 111 Kobayashi (10.1046/j.1523-1755.2000.00108.x_bb0135) 1999; 133 Yokoyama (10.1046/j.1523-1755.2000.00108.x_bb0125) 1999; 56 Myrup (10.1046/j.1523-1755.2000.00108.x_bb0130) 1995; 345 Sank (10.1046/j.1523-1755.2000.00108.x_bb0010) 1994; 57 Takeuchi (10.1046/j.1523-1755.2000.00108.x_bb0065) 1995; 268 Tamsma (10.1046/j.1523-1755.2000.00108.x_bb0115) 1994; 37 Mueller (10.1046/j.1523-1755.2000.00108.x_bb0070) 1997; 105 Mandal (10.1046/j.1523-1755.2000.00108.x_bb0045) 1995; 48 Curcio (10.1046/j.1523-1755.2000.00108.x_bb0020) 1992; 28A Mandal (10.1046/j.1523-1755.2000.00108.x_bb0040) 1995; 47 Cosio (10.1046/j.1523-1755.2000.00108.x_bb0075) 1995; 5 Rosenzweig (10.1046/j.1523-1755.2000.00108.x_bb0105) 1982; 47 Ferri (10.1046/j.1523-1755.2000.00108.x_bb0100) 1995; 80 UK Prospective Diabetics Study Group (10.1046/j.1523-1755.2000.00108.x_bb0030) 1998; 352 Yokokawa (10.1046/j.1523-1755.2000.00108.x_bb0055) 1993; 92 Imai (10.1046/j.1523-1755.2000.00108.x_bb0090) 1993; 21 Graier (10.1046/j.1523-1755.2000.00108.x_bb0060) 1995; 294 Yamauchi (10.1046/j.1523-1755.2000.00108.x_bb0085) 1990; 267 Yokokawa (10.1046/j.1523-1755.2000.00108.x_bb0050) 1992; 263 Inoguchi (10.1046/j.1523-1755.2000.00108.x_bb0095) 1994; 267 Susic (10.1046/j.1523-1755.2000.00108.x_bb0140) 1982; 4 Kasinath (10.1046/j.1523-1755.2000.00108.x_bb0120) 1996; 167 Kanwar (10.1046/j.1523-1755.2000.00108.x_bb0110) 1980; 86 Kamoi (10.1046/j.1523-1755.2000.00108.x_bb0015) 1994; 24 The Diabetes Control Complications Trial Research Group (10.1046/j.1523-1755.2000.00108.x_bb0025) 1998; 128 UK Prospective Diabetes Study Group (10.1046/j.1523-1755.2000.00108.x_bb0035) 1998; 317 |
References_xml | – volume: 24 start-page: 125 year: 1994 end-page: 129 ident: bb0015 article-title: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy publication-title: Diabetes Res Clin Pract contributor: fullname: Yamaji – volume: 128 start-page: 517 year: 1998 end-page: 523 ident: bb0025 article-title: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial publication-title: Ann Intern Med contributor: fullname: The Diabetes Control Complications Trial Research Group – volume: 80 start-page: 829 year: 1995 end-page: 835 ident: bb0100 article-title: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro publication-title: J Clin Endocrinol Metab contributor: fullname: Santucci – volume: 56 start-page: 650 year: 1999 end-page: 658 ident: bb0125 article-title: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy publication-title: Kidney Int contributor: fullname: Iwamoto – volume: 294 start-page: 221 year: 1995 end-page: 229 ident: bb0060 article-title: Intracellular mechanism of high publication-title: Eur J Pharmacol contributor: fullname: Kestner – volume: 268 start-page: F13 year: 1995 end-page: F19 ident: bb0065 article-title: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells publication-title: Am J Physiol contributor: fullname: Kashgarian – volume: 37 start-page: 313 year: 1994 end-page: 320 ident: bb0115 article-title: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane publication-title: Diabetologia contributor: fullname: Vander Woude – volume: 47 start-page: 1017 year: 1995 end-page: 1022 ident: bb0040 article-title: Heparin lowers blood pressure: Biological and clinical perspectives publication-title: Kidney Int contributor: fullname: Saklayen – volume: 167 start-page: 131 year: 1996 end-page: 136 ident: bb0120 article-title: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium publication-title: J Cell Physiol contributor: fullname: Abboud – volume: 48 start-page: 1508 year: 1995 end-page: 1516 ident: bb0045 article-title: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation publication-title: Kidney Int contributor: fullname: Colvin – volume: 267 start-page: 16 year: 1990 end-page: 18 ident: bb0085 article-title: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell publication-title: FEBS Lett contributor: fullname: Nawata – volume: 92 start-page: 2080 year: 1993 end-page: 2085 ident: bb0055 article-title: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells publication-title: J Clin Invest contributor: fullname: Takeda – volume: 21 start-page: 353 year: 1993 end-page: 358 ident: bb0090 article-title: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells publication-title: Hypertension contributor: fullname: Marumo – volume: 4 start-page: 681 year: 1982 end-page: 685 ident: bb0140 article-title: Heparin lowers blood pressure in hypertensive rats publication-title: Hypertension contributor: fullname: Kentera – volume: 57 start-page: 647 year: 1994 end-page: 653 ident: bb0010 article-title: Human endothelial cells are defective in diabetic vascular disease publication-title: J Surg Res contributor: fullname: Reid – volume: 263 start-page: R1035 year: 1992 end-page: R1041 ident: bb0050 article-title: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats publication-title: Am J Physiol contributor: fullname: Takeda – volume: 28A start-page: 787 year: 1992 end-page: 790 ident: bb0020 article-title: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications publication-title: In Vitro Cell Dev Biol contributor: fullname: Ceriello – volume: 317 start-page: 703 year: 1998 end-page: 713 ident: bb0035 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 publication-title: Br Med J contributor: fullname: UK Prospective Diabetes Study Group – volume: 86 start-page: 688 year: 1980 end-page: 693 ident: bb0110 article-title: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion publication-title: J Cell Biol contributor: fullname: Farquhar – volume: 352 start-page: 837 year: 1998 end-page: 853 ident: bb0030 article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes publication-title: Lancet contributor: fullname: UK Prospective Diabetics Study Group – volume: 111 start-page: 63 year: 1988 end-page: 72 ident: bb0145 article-title: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats publication-title: J Lab Clin Med contributor: fullname: Kentera – volume: 267 start-page: E369 year: 1994 end-page: E379 ident: bb0095 article-title: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue publication-title: Am J Physiol contributor: fullname: King – volume: 47 start-page: 177 year: 1982 end-page: 184 ident: bb0105 article-title: Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to publication-title: Lab Invest contributor: fullname: Kanwar – volume: 345 start-page: 421 year: 1995 end-page: 422 ident: bb0130 article-title: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus publication-title: Lancet contributor: fullname: Deckert – volume: 133 start-page: 134 year: 1999 end-page: 143 ident: bb0135 article-title: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change publication-title: J Lab Clin Med contributor: fullname: Takamura – volume: 5 start-page: 1600 year: 1995 end-page: 1609 ident: bb0075 article-title: Effects of high glucose concentrations on human mesangial cell proliferation publication-title: J Am Soc Nephrol contributor: fullname: Cosio – volume: 43 start-page: 878 year: 1994 end-page: 882 ident: bb0080 article-title: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo publication-title: Metabolism contributor: fullname: Fyhrquist – volume: 105 start-page: 32 year: 1997 end-page: 38 ident: bb0070 article-title: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C publication-title: Exp Clin Endocrinol Diabetes contributor: fullname: Landgraf – volume: 128 start-page: 517 year: 1998 end-page: 523 article-title: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial. publication-title: Ann Intern Med – volume: 47 start-page: 1017 year: 1995 end-page: 1022 article-title: Heparin lowers blood pressure: Biological and clinical perspectives. publication-title: Kidney Int contributor: fullname: Saklayen, MG – volume: 352 start-page: 837 year: 1998 end-page: 853 article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes publication-title: Lancet – volume: 111 start-page: 63 year: 1988 end-page: 72 article-title: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats. publication-title: J Lab Clin Med contributor: fullname: Kentera, D – volume: 28A start-page: 787 year: 1992 end-page: 790 article-title: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications. publication-title: In Vitro Cell Dev Biol contributor: fullname: Ceriello, A – volume: 43 start-page: 878 year: 1994 end-page: 882 article-title: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. publication-title: Metabolism contributor: fullname: Fyhrquist, F – volume: 56 start-page: 650 year: 1999 end-page: 658 article-title: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy. publication-title: Kidney Int contributor: fullname: Iwamoto, Y – volume: 47 start-page: 177 year: 1982 end-page: 184 article-title: Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to I albumin. publication-title: Lab Invest contributor: fullname: Kanwar, YS – volume: 268 start-page: F13 year: 1995 end-page: F19 article-title: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. publication-title: Am J Physiol contributor: fullname: Kashgarian, M – volume: 37 start-page: 313 year: 1994 end-page: 320 article-title: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane. publication-title: Diabetologia contributor: fullname: Vander Woude, FJ – volume: 267 start-page: E369 year: 1994 end-page: E379 article-title: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue. publication-title: Am J Physiol contributor: fullname: King, GL – volume: 133 start-page: 134 year: 1999 end-page: 143 article-title: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change. publication-title: J Lab Clin Med contributor: fullname: Takamura, T – volume: 24 start-page: 125 year: 1994 end-page: 129 article-title: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy. publication-title: Diabetes Res Clin Pract contributor: fullname: Yamaji, T – volume: 92 start-page: 2080 year: 1993 end-page: 2085 article-title: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. publication-title: J Clin Invest contributor: fullname: Takeda, T – volume: 86 start-page: 688 year: 1980 end-page: 693 article-title: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. publication-title: J Cell Biol contributor: fullname: Farquhar, MG – volume: 48 start-page: 1508 year: 1995 end-page: 1516 article-title: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation. publication-title: Kidney Int contributor: fullname: Colvin, RB – volume: 57 start-page: 647 year: 1994 end-page: 653 article-title: Human endothelial cells are defective in diabetic vascular disease. publication-title: J Surg Res contributor: fullname: Reid, J – volume: 4 start-page: 681 year: 1982 end-page: 685 article-title: Heparin lowers blood pressure in hypertensive rats. publication-title: Hypertension contributor: fullname: Kentera, D – volume: 267 start-page: 16 year: 1990 end-page: 18 article-title: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell. publication-title: FEBS Lett contributor: fullname: Nawata, H – volume: 167 start-page: 131 year: 1996 end-page: 136 article-title: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium. publication-title: J Cell Physiol contributor: fullname: Abboud, SL – volume: 80 start-page: 829 year: 1995 end-page: 835 article-title: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro. publication-title: J Clin Endocrinol Metab contributor: fullname: Santucci, A – volume: 21 start-page: 353 year: 1993 end-page: 358 article-title: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells. publication-title: Hypertension contributor: fullname: Marumo, F – volume: 5 start-page: 1600 year: 1995 end-page: 1609 article-title: Effects of high glucose concentrations on human mesangial cell proliferation. publication-title: J Am Soc Nephrol contributor: fullname: Cosio, F – volume: 105 start-page: 32 year: 1997 end-page: 38 article-title: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C. publication-title: Exp Clin Endocrinol Diabetes contributor: fullname: Landgraf, R – volume: 294 start-page: 221 year: 1995 end-page: 229 article-title: Intracellular mechanism of high -glucose-induced modulation of vascular proliferation. publication-title: Eur J Pharmacol contributor: fullname: Kestner, GM – volume: 345 start-page: 421 year: 1995 end-page: 422 article-title: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. publication-title: Lancet contributor: fullname: Deckert, T – volume: 263 start-page: R1035 year: 1992 end-page: R1041 article-title: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. publication-title: Am J Physiol contributor: fullname: Takeda, T – volume: 317 start-page: 703 year: 1998 end-page: 713 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. publication-title: Br Med J – volume: 4 start-page: 681 year: 1982 ident: 10.1046/j.1523-1755.2000.00108.x_bb0140 article-title: Heparin lowers blood pressure in hypertensive rats publication-title: Hypertension doi: 10.1161/01.HYP.4.5.681 contributor: fullname: Susic – volume: 294 start-page: 221 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0060 article-title: Intracellular mechanism of high D-glucose-induced modulation of vascular proliferation publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(95)00534-X contributor: fullname: Graier – volume: 267 start-page: E369 year: 1994 ident: 10.1046/j.1523-1755.2000.00108.x_bb0095 article-title: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue publication-title: Am J Physiol contributor: fullname: Inoguchi – volume: 128 start-page: 517 year: 1998 ident: 10.1046/j.1523-1755.2000.00108.x_bb0025 article-title: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-128-7-199804010-00001 contributor: fullname: The Diabetes Control Complications Trial Research Group – volume: 47 start-page: 177 year: 1982 ident: 10.1046/j.1523-1755.2000.00108.x_bb0105 article-title: Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I albumin publication-title: Lab Invest contributor: fullname: Rosenzweig – volume: 345 start-page: 421 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0130 article-title: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus publication-title: Lancet doi: 10.1016/S0140-6736(95)90403-4 contributor: fullname: Myrup – volume: 92 start-page: 2080 year: 1993 ident: 10.1046/j.1523-1755.2000.00108.x_bb0055 article-title: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells publication-title: J Clin Invest doi: 10.1172/JCI116805 contributor: fullname: Yokokawa – volume: 37 start-page: 313 year: 1994 ident: 10.1046/j.1523-1755.2000.00108.x_bb0115 article-title: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane publication-title: Diabetologia doi: 10.1007/BF00398060 contributor: fullname: Tamsma – volume: 24 start-page: 125 year: 1994 ident: 10.1046/j.1523-1755.2000.00108.x_bb0015 article-title: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy publication-title: Diabetes Res Clin Pract doi: 10.1016/0168-8227(94)90107-4 contributor: fullname: Kamoi – volume: 56 start-page: 650 year: 1999 ident: 10.1046/j.1523-1755.2000.00108.x_bb0125 article-title: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy publication-title: Kidney Int doi: 10.1046/j.1523-1755.1999.00591.x contributor: fullname: Yokoyama – volume: 43 start-page: 878 year: 1994 ident: 10.1046/j.1523-1755.2000.00108.x_bb0080 article-title: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo publication-title: Metabolism doi: 10.1016/0026-0495(94)90270-4 contributor: fullname: Metsarinne – volume: 86 start-page: 688 year: 1980 ident: 10.1046/j.1523-1755.2000.00108.x_bb0110 article-title: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion publication-title: J Cell Biol doi: 10.1083/jcb.86.2.688 contributor: fullname: Kanwar – volume: 80 start-page: 829 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0100 article-title: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro publication-title: J Clin Endocrinol Metab contributor: fullname: Ferri – volume: 48 start-page: 1508 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0045 article-title: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation publication-title: Kidney Int doi: 10.1038/ki.1995.441 contributor: fullname: Mandal – volume: 111 start-page: 63 year: 1988 ident: 10.1046/j.1523-1755.2000.00108.x_bb0145 article-title: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats publication-title: J Lab Clin Med contributor: fullname: Susic – volume: 167 start-page: 131 year: 1996 ident: 10.1046/j.1523-1755.2000.00108.x_bb0120 article-title: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium publication-title: J Cell Physiol doi: 10.1002/(SICI)1097-4652(199604)167:1<131::AID-JCP15>3.0.CO;2-E contributor: fullname: Kasinath – volume: 28A start-page: 787 year: 1992 ident: 10.1046/j.1523-1755.2000.00108.x_bb0020 article-title: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications publication-title: In Vitro Cell Dev Biol doi: 10.1007/BF02631069 contributor: fullname: Curcio – volume: 47 start-page: 1017 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0040 article-title: Heparin lowers blood pressure: Biological and clinical perspectives publication-title: Kidney Int doi: 10.1038/ki.1995.147 contributor: fullname: Mandal – volume: 352 start-page: 837 year: 1998 ident: 10.1046/j.1523-1755.2000.00108.x_bb0030 article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes publication-title: Lancet doi: 10.1016/S0140-6736(98)07019-6 contributor: fullname: UK Prospective Diabetics Study Group – volume: 263 start-page: R1035 year: 1992 ident: 10.1046/j.1523-1755.2000.00108.x_bb0050 article-title: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats publication-title: Am J Physiol contributor: fullname: Yokokawa – volume: 268 start-page: F13 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0065 article-title: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells publication-title: Am J Physiol contributor: fullname: Takeuchi – volume: 5 start-page: 1600 year: 1995 ident: 10.1046/j.1523-1755.2000.00108.x_bb0075 article-title: Effects of high glucose concentrations on human mesangial cell proliferation publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V581600 contributor: fullname: Cosio – volume: 267 start-page: 16 year: 1990 ident: 10.1046/j.1523-1755.2000.00108.x_bb0085 article-title: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell publication-title: FEBS Lett doi: 10.1016/0014-5793(90)80276-O contributor: fullname: Yamauchi – volume: 317 start-page: 703 year: 1998 ident: 10.1046/j.1523-1755.2000.00108.x_bb0035 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 publication-title: Br Med J doi: 10.1136/bmj.317.7160.703 contributor: fullname: UK Prospective Diabetes Study Group – volume: 133 start-page: 134 year: 1999 ident: 10.1046/j.1523-1755.2000.00108.x_bb0135 article-title: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change publication-title: J Lab Clin Med doi: 10.1016/S0022-2143(99)90006-9 contributor: fullname: Kobayashi – volume: 105 start-page: 32 year: 1997 ident: 10.1046/j.1523-1755.2000.00108.x_bb0070 article-title: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C publication-title: Exp Clin Endocrinol Diabetes doi: 10.1055/s-0029-1211724 contributor: fullname: Mueller – volume: 57 start-page: 647 year: 1994 ident: 10.1046/j.1523-1755.2000.00108.x_bb0010 article-title: Human endothelial cells are defective in diabetic vascular disease publication-title: J Surg Res doi: 10.1006/jsre.1994.1195 contributor: fullname: Sank – volume: 21 start-page: 353 year: 1993 ident: 10.1046/j.1523-1755.2000.00108.x_bb0090 article-title: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells publication-title: Hypertension doi: 10.1161/01.HYP.21.3.353 contributor: fullname: Imai |
SSID | ssj0008930 |
Score | 1.7467865 |
Snippet | Effect of insulin and heparin on glucose-induced vascular damage in cell culture.
Clinical trials have shown that tight glycemic control reduces the risk of... Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and... |
SourceID | proquest crossref pubmed nature elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2492 |
SubjectTerms | cell adhesion Cell Line D-glucose diabetic vascular complications endothelial cells Endothelin-1 - metabolism Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Fluorescent Antibody Technique Glucose - pharmacology Heparin - pharmacology Insulin - pharmacology Microscopy, Electron Microscopy, Electron, Scanning Osmolar Concentration Vascular Diseases - chemically induced Vascular Diseases - metabolism Vascular Diseases - pathology |
Title | Effect of insulin and heparin on glucose-induced vascular damage in cell culture |
URI | https://dx.doi.org/10.1046/j.1523-1755.2000.00108.x http://dx.doi.org/10.1046/j.1523-1755.2000.00108.x https://www.ncbi.nlm.nih.gov/pubmed/10844618 https://www.proquest.com/docview/210103900 |
Volume | 57 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3di9NAEF96J4gv4tdpPZV98K1sSdLd7QafDq2eVEWwD76FZHfD9fDSw15B_3tn9itGK5yILyGk5Gvm18nM7MxvCHmuBEfSkYZpXbaM65qzupg1TOhaFxZCucw1Cp9-mn_4rF4t-GI0iqOf-mP_VdNwDHSNnbN_oe10UTgA-6Bz2ILWYXstvQc6YscE4cvMMTV-ZnHaYIdLA6FInUEwvsPF_1SLauoLLODBwnRM6HlOjkGl0HJtOvvdUUykLGKf0obg3q_4d-svk-U0Gd2dPoO39uOxY7J-skq_v7MXYJjYG2xK3F6uf68V6pMKqV1xcjIdpCuyvqzK59BiH82gzBMdP1YIz_MytcEUF0ie6kl8o632ZNYBkwPDy_1IvfARB8cu3_uByBwz8vk0Xd31KuF6VKZi4eiAfhtbyQU-Gviac9w_IDcKMGoufH-7TF998Pt8u1N4k1A1FlbQ997tj67QgNN1T8zjfJ_VHXI7BC30xKPtLhnZ7h65-T6UZdwnHz3o6KalAXQU0EAD6Oimo7-AjkbQUQ86OI0i6GgA3QOyer1YvTxlYVQH01yWV6zgtVFGiRIcInS7ZNlI3WazeataY7hohGlynpsGfKa2UeBjSm61tIa3LddidkQOu01nH4HQcmlAzrrQ4FzOpCglBMBwgbLRRsJ5Y5JHoVWXnpClcoUUHJsOUdAVChrHqyLxLQi6-jYmL6J0q-BYeoexAlhc4-wjr5B0PzBvuVDlmBxHBVXBAmyrIsfJKWWWjclDr7OfHlNxLnP1-J8e55jc6v9XT8jh1dedfUoOtmb3zCHyBxmrsRM |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+insulin+and+heparin+on+glucose-induced+vascular+damage+in+cell+culture&rft.jtitle=Kidney+international&rft.au=Mandal%2C+Anil+K.&rft.au=Puchalski%2C+Jonathan+T.&rft.au=Lemley-Gillespie%2C+Susan&rft.au=Taylor%2C+Catherine+A.&rft.date=2000-06-01&rft.pub=Elsevier+Inc&rft.issn=0085-2538&rft.eissn=1523-1755&rft.volume=57&rft.issue=6&rft.spage=2492&rft.epage=2501&rft_id=info:doi/10.1046%2Fj.1523-1755.2000.00108.x&rft.externalDocID=S0085253815470085 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0085-2538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0085-2538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0085-2538&client=summon |